Best Chondrosarcoma doctors in Israel: TOP 7 doctors

Leader in sarcoma treatment with 41 years of experience heading the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center.

• Fellowship-trained at Institut Gustave Roussy in Paris, a world-renowned sarcoma center
• Faculty member of the European Society of Medical Oncology (ESMO) Sarcoma group
• Published extensively on orthopedic oncology and treatment protocols

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Director of pediatric hematology oncology at Sourasky Medical Center – specializes in bone cancer treatment for children.

• Expert in sarcoma treatment for children
• Trained at Rizzoli Orthopaedic Institute – a world-leading center
• Coordinates bone cancer treatment with oncology-orthopedic teams
• Member of ISPHO – Israel's pediatric hemato-oncology association

Heads a department dedicated to metastatic bone lesions at Ichilov Medical Center – one of Israel's largest hospitals.

• Specializes exclusively in oncological orthopedics, treating bone cancers.
• Completed advanced clinical internships in Israel and the United States.
• Holds a senior academic position as a Professor at Tel Aviv University.
• Educated at the prestigious Hebrew University of Jerusalem.

Dr. Amir is a specialist in limb-sparing surgery for bone and soft tissue cancers at Israel's Sourasky Medical Center (Ichilov).

• Fellowship-trained in orthopedic oncology at the US National Cancer Institute and the University of Toronto
• Active member of the American Musculoskeletal Tumor Society (MSTS) and the International Society of Limb Salvage (ISOLS)
• Multiple award winner, including the Tannenbaum Grant for Excellence in Surgical Oncology
• Focuses on sarcomas, with expertise in complex cases requiring reconstructive techniques

Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.

He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.